BSEGeneral16 Oct 2026 · 16 Oct 2026, 05:04 pm
Intimation regarding payment of interest and redemption of Non-Convertible Debentures ("NCD")
Mankind Pharma Ltd · 543904
✦ AI SummaryResults
Mankind Pharma Ltd has paid interest and redeemed Non-Convertible Debentures (NCDs) to its holders on October 16, 2026, as per Regulation 57(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Mankind Pharma Ltd - 543904 - Compliances-Reg. 57 (1) - Certificate of interest payment/Principal in case of NCD
Attachments (1)
📄pdf
Download →
8ad9abc3-6bb8-4b0c-8204-a129d760dc5a.pdf
View document text
October 16, 2026
BSE Limited
P J Towers,
Dalal Street,
Mumbai – 400 001
Dear Sir/ Madam,
Subject: Intimation regarding payment of interest and redemption of Non-Convertible Debentures (“NCDs”)
Ref: Regulation 57(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“Listing Regulations”)
Pursuant to Regulation 57(1) of the Listing Regulations and in furtherance to our letter dated September 23, 2026, we
wish to inform that the Company has paid the interest and redemption amount to the NCD holders of the Company on
October 16, 2026.
The details of the payment as required under SEBI Master Circular No. SEBI/HO/DDHS/DDHS-
PoD/P/CIR/2025/0000000137 dated October 15, 2025 are as under:
a. Whether Interest payment/ redemption payment made (yes/ no): Yes
b. Details of interest payments:
S. Particulars Details
1 ISIN INE634S07025 INE634S07033
2 Issue size (Amount in ₹) 12,50,00,00,000 25,00,00,00,000
3 Interest Amount to be paid on due date (Amount in ₹) Gross Amount: Gross Amount:
500,743,150 998,979,452
Net of Taxes: Net of Taxes:
499,741,677 998,579,873
4 Frequency- quarterly/monthly/half yearly/yearly half yearly half yearly
5 Change in frequency of payment, if any NA NA
6 Details of such change NA NA
7 Interest payment record date 01/10/2026 01/10/2026
8 Due date for interest payment 16/10/2026 16/10/2026
9 Actual date for interest payment 16/10/2026 16/10/2026
10 Amount of interest paid (Amount in ₹) Gross Amount: Gross Amount:
500,743,150 998,979,452
Net of Taxes: Net of Taxes:
499,741,677 998,579,873
11 Date of last interest payment 01/04/2026 01/04/2026
12 Reason for non-payment/ delay in payment NA NA
c. Details of redemption payments
S. Particulars Details
1 ISIN INE634S07025
2 Type of redemption (full/ partial) Full
3 If partial redemption, then NA
a. By face value redemption NA
b. By quantity redemption NA
4 If redemption is based on quantity, specify, whether on: NA
a. Lot basis NA
b. Pro-rata basis NA
5 Reason for redemption (call, put, premature redemption, Maturity
maturity, buyback, conversion, others (if any))
6 Redemption date due to put option (if any) NA
7 Redemption date due to call option (if any) NA
8 Quantity redeemed (No. of NCDs) 1,25,000
9 Due date for redemption/ maturity 16/10/2026
10 Actual date for redemption 16/10/2026
11 Amount redeemed 12,50,00,00,000
12 Outstanding amount (₹) 0
13 Date of last Interest payment 16/10/2026
14 Reason for non-payment/ delay in payment NA
The information in the above intimation is also being uploaded on the website of the Company at
www.mankindpharma.com.
This is for your information and records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Hitesh Kumar Jain
Company Secretary &
Compliance Officer